Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer

PURPOSE: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature suggests that surgery after CRT for stage III NSC...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Adv Radiat Oncol
Main Authors: Vyfhuis, Melissa A.L., Bhooshan, Neha, Burrows, Whitney M., Turner, Michelle, Suntharalingam, Mohan, Donahue, James, Nichols, Elizabeth M., Feliciano, Josephine, Bentzen, Søren M., Badiyan, Shahed, Carr, Shamus R., Friedberg, Joseph, Simone, Charles B., Edelman, Martin J., Feigenberg, Steven J., Mohindra, Pranshu
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2017
נושאים:
ROI Value of RT Publication Award Winner
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5605306/
https://ncbi.nlm.nih.gov/pubmed/29114590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2017.07.009
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים